Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 5
1987 11
1988 8
1989 20
1990 20
1991 22
1992 24
1993 30
1994 16
1995 23
1996 20
1997 24
1998 11
1999 13
2000 19
2001 14
2002 27
2003 18
2004 25
2005 17
2006 21
2007 21
2008 24
2009 31
2010 40
2011 33
2012 38
2013 34
2014 35
2015 49
2016 47
2017 52
2018 54
2019 49
2020 55
2021 57
2022 51
2023 45
2024 82
2025 92
2026 62

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,181 results

Results by year

Filters applied: . Clear all
Page 1
Ivermectin: a mini-review.
Johnson-Arbor K. Johnson-Arbor K. Clin Toxicol (Phila). 2022 May;60(5):571-575. doi: 10.1080/15563650.2022.2043338. Epub 2022 Feb 28. Clin Toxicol (Phila). 2022. PMID: 35225114 Review.
Ivermectin to Control Malaria - A Cluster-Randomized Trial.
Chaccour C, Maia M, Kariuki M, Ruiz-Castillo P, Wanjiku C, Kasiwa L, Brazeal A, Casellas A, Ngama M, Onyango T, Elobolobo E, Kazungu K, Mael M, Wangari W, Nuru K, Otuko R, Sanz A, Ringera I, Matano A, Mitora S, Ribes M, Brew J, Gorski N, Nicolas P, Stanulovic S, Omondi I, Furnival-Adams J, Túnez L, Mbarak J, Vegove V, Yaa E, Mramba S, Kibet Y, Nyambura N, Rotich C, Wanjiru S, Vura M, Wanjiku F, Sam L, Collins L, Xia K, Hammann F, Saúte F, Rudd M, Rist C, Jones C, Mwangangi J, Rabinovich NR. Chaccour C, et al. N Engl J Med. 2025 Jul 24;393(4):362-375. doi: 10.1056/NEJMoa2411262. N Engl J Med. 2025. PMID: 40700688 Clinical Trial.
Ivermectin and non-parasitic disorders: An update.
Seyyedabadi B, Babataheri S, Naseri M, Laher I, Soraya H. Seyyedabadi B, et al. Curr Opin Pharmacol. 2025 Dec;85:102574. doi: 10.1016/j.coph.2025.102574. Epub 2025 Sep 16. Curr Opin Pharmacol. 2025. PMID: 41063670 Review.
Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trial.
Boralevi F, Simon G, Bernigaud C, Brun J, Goujon E, Perrot JL, Phan A, Hérissé AL, Maruani A, Vanhaecke C, Couty E, Abasq-Thomas C, Fournet M, Mallet S, Brenaut E, Hubiche T, Balguerie X, Caux F, Beneton N, Dutkiewicz AS, Adamski H, Aubert H, Bourrat E, Couzan C, Eyraud A, Janela-Lapert R, Marti A, Miquel J, Richard M, Barbarot S, Bonniaud B, Chabbert C, Delion F, Dinulescu M, Duong TA, Etienne M, Hirsch G, Isnard C, Huet F, Le Bidre E, Leducq S, Legrand A, Monestier S, Morice-Picard F, Seneschal J, Capelli A, Lacoste C, Labrèze C, Miraglia G, Do-Pham G, Giraudeau B, Chosidow O. Boralevi F, et al. BMJ. 2026 Jan 6;392:e086277. doi: 10.1136/bmj-2025-086277. BMJ. 2026. PMID: 41494769 Free PMC article. Clinical Trial.
Adverse drug reactions and ivermectin in COVID-19.
Montastruc JL. Montastruc JL. Therapie. 2022 Nov-Dec;77(6):633-634. doi: 10.1016/j.therap.2022.04.003. Epub 2022 Apr 27. Therapie. 2022. PMID: 35599192 Free PMC article. No abstract available.
Ivermectin drug induced liver injury.
Sonderup M, Mudini W, Spearman W. Sonderup M, et al. S Afr Med J. 2023 Jun 5;113(6):24-25. doi: 10.7196/SAMJ.2023.v113i6.624. S Afr Med J. 2023. PMID: 37278267 Free article.
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Naggie S, Boulware DR, Lindsell CJ, Stewart TG, Gentile N, Collins S, McCarthy MW, Jayaweera D, Castro M, Sulkowski M, McTigue K, Thicklin F, Felker GM, Ginde AA, Bramante CT, Slandzicki AJ, Gabriel A, Shah NS, Lenert LA, Dunsmore SE, Adam SJ, DeLong A, Hanna G, Remaly A, Wilder R, Wilson S, Shenkman E, Hernandez AF; Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-6) Study Group and Investigators. Naggie S, et al. JAMA. 2022 Oct 25;328(16):1595-1603. doi: 10.1001/jama.2022.18590. JAMA. 2022. PMID: 36269852 Free PMC article. Clinical Trial.
The Effect of Ivermectin on Cases of COVID-19.
Annie FH, Campbell J, Searls L, Amos J. Annie FH, et al. Cardiovasc Revasc Med. 2022 Nov;44:98-100. doi: 10.1016/j.carrev.2022.06.004. Epub 2022 Jun 17. Cardiovasc Revasc Med. 2022. PMID: 35729025 Free PMC article.
Efficacy and safety of ivermectin for treatment of non-hospitalized COVID-19 patients: A systematic review and meta-analysis of 12 randomized controlled trials with 7,035 participants.
Hernandez AV, Liu A, Roman YM, Burela PA, Pasupuleti V, Thota P, Carranza-Tamayo CO, Retamozo-Palacios M, Benites-Zapata VA, Piscoya A, Vidal JE. Hernandez AV, et al. Int J Antimicrob Agents. 2024 Aug;64(2):107248. doi: 10.1016/j.ijantimicag.2024.107248. Epub 2024 Jun 20. Int J Antimicrob Agents. 2024. PMID: 38908535
1,181 results